Clinical Trial

Enteral Lipid Supplementation and Bronchoplumonary Dysplasia of Premature Infants

Name: Enteral Lipid Supplementation and Bronchoplumonary Dysplasia of Premature Infants — clinical trial record (NCT07652684)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PRELUDE

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The Impact of Omega-3 (DHA - Docosahexaenoic Acid) and Omega-6 (ARA - Arachidonic Acid) Supplementation on the Development of Bronchopulmonary Dysplasia in Extremely and Very Preterm Infants (24-29 weeks of gestational age).

Trial Details

NCT Number	NCT07652684
Lead Sponsor	Aristotle University Of Thessaloniki
Conditions	Bronchopulmonary Dysplasia (BPD)
Enrollment	74 participants
Start Date	2025-03-04
Primary Completion	2026-11-30 (estimated)
Study Completion	2027-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-17